Cargando…
A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients
Desmopressin (dDAVP) is a well-known peptide analog of the antidiuretic hormone vasopressin, used to prevent excessive bleeding during surgical procedures. dDAVP increases hemostatic mediators, such as the von Willebrand factor (vWF), recently considered a key element in resistance to metastasis. St...
Autores principales: | Weinberg, Ruth S, Grecco, Marcelo O, Ferro, Gimena S, Seigelshifer, Debora J, Perroni, Nancy V, Terrier, Francisco J, Sánchez-Luceros, Analía, Maronna, Esteban, Sánchez-Marull, Ricardo, Frahm, Isabel, Guthmann, Marcelo D, Di Leo, Daniela, Spitzer, Eduardo, Ciccia, Graciela N, Garona, Juan, Pifano, Marina, Torbidoni, Ana V, Gomez, Daniel E, Ripoll, Giselle V, Gomez, Roberto E, Demarco, Ignacio A, Alonso, Daniel F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540720/ https://www.ncbi.nlm.nih.gov/pubmed/26306290 http://dx.doi.org/10.1186/s40064-015-1217-y |
Ejemplares similares
-
Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial
por: Iseas, Soledad, et al.
Publicado: (2020) -
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
por: Ripoll, Giselle V., et al.
Publicado: (2013) -
Metastasis: Recent Discoveries and Novel Perioperative Treatment Strategies with Particular Interest in the Hemostatic Compound Desmopressin
por: Alonso, D.F, et al.
Publicado: (2011) -
The novel desmopressin analogue [V(4)Q(5)]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models
por: GARONA, JUAN, et al.
Publicado: (2015) -
Efficient and Straightforward Syntheses of Two United
States Pharmacopeia Sitagliptin Impurities: 3-Desamino-2,3-dehydrositagliptin
and 3-Desamino-3,4-dehydrositagliptin
por: Sova, Matej, et al.
Publicado: (2020)